The trial by Cambridge University Hospitals includes up to 18 children from the UK, Spain and the US, born with hearing loss due to auditory neuropathy — a condition caused by the disr… Read More
Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurrent GBM associated with survival of less than 10 months. Immunotherapies, which mobilize the… Read More
An anonymous reader quotes a report from the Financial Times: A world-first trial of a gene therapy to cure a form of deafness has begun, potentially heralding a revolution in the treatment… Read More
HIV (human immunodeficiency virus) is a devastating global health crisis that has affected millions of individuals worldwide; in 2022 alone, nearly 39 million individuals were living with th… Read More
Español
As told to Nicole Audrey Spector
When I was a baby, I was diagnosed with beta thalassemia, a rare blood disorder that makes you unable to produce enough healthy red blood c… Read More
PLUS: Citing Hamas, the US Wants to Treat Crypto Anonymity Services as Suspected Money Launderers, and more.View this email in your browser | Manage newsletter subscriptions … Read More
Biotech is a hot sector. It’s on the cutting edge of science and technology and that always attracts investor attention. But what is biotech, really, and what are the best biotech stoc… Read More
Developing new therapies requires a deep understanding of cancer hallmarks. This (Cancer Research Data is Changing the Treatment Landscape) requires massive amounts of molecular and phenotyp… Read More
[Oct. 10, 2023: Staff Writer, The Brighter Side of News] One day, protecting our cells from aging may be as easy as taking a pill. (CREDIT: Creative Commons)Though the quest for an eternal… Read More
Retinitis Pigmentosa News 2023 is here, and it’s important to understand the implications of this Retinitis Pigmentosa News 2023. Retinitis Pigmentosa is a degenerative eye condition t… Read More
[Sept. 30, 2023: Staff Writer, The Brighter Side of News] The work serves as a foundational guide for physicians and scientists to understand disease development and improve treatment outco… Read More
Company to Provide Updates on Phase 2 Clinical Trials
for Next Generation COVID-19 Vaccine and Cancer Immunotherapy Programs
ATLANTA, GA – (NewMediaWire) –… Read More
Preclinical Data for GEO-CM02 Demonstrates Single-Dose Protection
Against Multiple SARS-CoV-2 Variants
ATLANTA, GA – (NewMediaWire) – September 20, 2023 – GeoVax L… Read More